ZUNESTAR 2 Tablet is a pharmaceutical product containing Eszopiclone 2 mg, a potent non-benzodiazepine hypnotic agent prescribed primarily for the treatment of insomnia, including difficulties with sleep onset and sleep maintenance. Eszopiclone is the active S-enantiomer of zopiclone and is recognized for its longer half-life and superior binding affinity to the GABA-A receptor, making it effective for both sleep initiation and sustained sleep quality throughout the night.
ZUNESTAR 2 works by enhancing the action of gamma-aminobutyric acid (GABA), the brain's primary inhibitory neurotransmitter. This modulation leads to a calming effect on the central nervous system, which helps in reducing the time taken to fall asleep, increasing total sleep time, and minimizing nocturnal awakenings. Eszopiclone 2 mg is generally administered right before bedtime, offering a balance between efficacy and tolerability with minimal next-day sedation in most patients.
ZUNESTAR 2 is produced in WHO-GMP-compliant and ISO-certified manufacturing facilities by BluepillExpress, ensuring a globally recognized standard of pharmaceutical quality. Each tablet is manufactured using precision-controlled processes, resulting in uniform potency and bioavailability across batches. The product is packaged in moisture-resistant, tamper-proof blister packs to protect it from degradation and maintain efficacy throughout its shelf life.
Clinically, Eszopiclone is preferred over many older sedative agents due to its lower risk of dependence and milder withdrawal symptoms. The 2 mg strength is considered suitable for most adult patients, especially those who require assistance with both falling and staying asleep. It is particularly beneficial in patients experiencing moderate to severe insomnia, including cases associated with anxiety, depression, or lifestyle-related stress.
ZUNESTAR 2 is generally well tolerated, with common side effects such as mild metallic taste, headache, or dry mouth. It does not typically cause significant memory impairment or cognitive dullness, especially when used as directed for short durations. It is not intended for long-term use unless prescribed by a physician with careful monitoring. The use of this medication in elderly individuals or those with hepatic impairment should be undertaken with caution and possibly at a reduced dose.
ZUNESTAR 2 should not be taken with alcohol, opioids, or other central nervous system depressants due to the risk of enhanced sedative effects, respiratory depression, and psychomotor impairment. It is also contraindicated in individuals with a history of substance abuse, sleep apnea, myasthenia gravis, or severe respiratory disorders. As with all hypnotic medications, there is a potential for misuse, so patients should be carefully selected and monitored.
Manufactured under stringent regulatory frameworks by BluepillExpress, ZUNESTAR 2 comes with complete quality documentation including Certificate of Analysis (COA), stability data, and regulatory compliance support. BluepillExpress also provides custom private-label packaging, bulk order fulfillment, and international shipping assistance for regulated and semi-regulated markets.
ZUNESTAR 2 Tablet offers a modern, evidence-based approach to insomnia treatment with a focus on efficacy, patient safety, and ease of administration. It is a trusted choice for physicians, hospitals, and pharmacies seeking a reliable solution for sleep disorders. With BluepillExpress as your third-party manufacturing partner, clients receive consistent product quality, global logistics coordination, and comprehensive branding support tailored to market needs.
ZUNESTAR 2 stands out as an advanced therapeutic option for patients requiring a dependable, well-studied, and internationally recognized solution for the management of insomnia. Its production and supply are carefully handled to ensure customer satisfaction, regulatory transparency, and uninterrupted availability.
Description provided by bluepill express.
FIEO Registered
Export Ready
